Clinician's Roundtable The Adult Shingles Vaccine: Challenges of Delivery
Mar 13, 2008
00:00
Host: Mark Nolan Hill, MD
Guest: Michael Oxman, MD
Guest: William Schaffner, MD
A vaccine for adult Shingles was officially licensed for use in 2006, but recent data shows that delivery of this vaccination has been a challenge. What are some of the issues which are limiting the distribution of the Shingles vaccine? How can we best address these difficulties? For expert insight on these questions and more, host Dr. Mark Nolan Hill welcomes Dr. Michael Oxman, professor of medicine and pathology at the University of California, San Diego School of Medicine, and Dr. William Schaffner, professor and chair of preventive medicine and professor of medicine in the department of infectious diseases at Vanderbilt University School of Medicine.
Guest: Michael Oxman, MD
Guest: William Schaffner, MD
A vaccine for adult Shingles was officially licensed for use in 2006, but recent data shows that delivery of this vaccination has been a challenge. What are some of the issues which are limiting the distribution of the Shingles vaccine? How can we best address these difficulties? For expert insight on these questions and more, host Dr. Mark Nolan Hill welcomes Dr. Michael Oxman, professor of medicine and pathology at the University of California, San Diego School of Medicine, and Dr. William Schaffner, professor and chair of preventive medicine and professor of medicine in the department of infectious diseases at Vanderbilt University School of Medicine.